Clinical Trial Update: Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of AGS-004 during analytical treatment interruption in HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• AGS-004

Snippet

Sponsor: Argos Therapeutics | Conditions: HIV Infection | Phase 2 | Status: COMPLETED